COMMUNIQUÉS West-GlobeNewswire

-
Umbrellux DAO Provides Solution to Americans Who Thought They Had an Allergy, but Really Suffer from Histamine Intolerance
14/02/2019 -
Cannabis Beverages Coming Soon! Which of These 4 Brands Will Be on Store Shelves First?
14/02/2019 -
Radius Health to Announce Fourth Quarter and Full Year 2018 Financial Results, Host Conference Call and Live Webcast on Thursday, February 28, 2019
14/02/2019 -
NovuHealth Data Showcases the Value of Annual Wellness Visits for Medicare and Medicaid Members
14/02/2019 -
Eloxx Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference in New York City on Friday, March 1, 2019
14/02/2019 -
Tauriga Sciences Inc. Taking Concrete Steps to Sell Tauri-Gum™ on Amazon
14/02/2019 -
Sarepta Announces FDA Acceptance of Golodirsen (SRP-4053) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53
14/02/2019 -
Assure Holdings Closes $3 Million Loan Facility
14/02/2019 -
American Cannabis Company, Inc. Announces Hemp Business Development & Appointment of Chief Operations Officer
14/02/2019 -
Achaogen Submits Response to ASPR/BARDA Request for Information (RFI) for Antimicrobial Resistance Project BioShield
14/02/2019 -
Achaogen Provides Update on Corporate Progress and Key Preliminary Fourth Quarter 2018 Results
14/02/2019 -
Ultragenyx and Kyowa Kirin Announce Positive 64-Week Results for Crysvita® (burosumab) from Phase 3 Study in Children with X-linked Hypophosphatemia (XLH)
14/02/2019 -
Precipio 2018 Revenues Increase 66% over 2017; Company Takes Substantial Cost-Cutting Measures Towards Profitability
14/02/2019 -
Fortune Magazine names Stryker one of the 100 Best Companies to Work For in 9th consecutive year
14/02/2019 -
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2019
14/02/2019 -
Medtronic and Medical University of South Carolina Partner to Improve Patient Outcomes
14/02/2019 -
Milestone Scientific Announces Private Placement by Entity Affiliated with Board Member & CEO of the Company’s Wand Dental Subsidiary
14/02/2019 -
Foamix Pharmaceuticals Fourth Quarter Financial Results Conference Call & Webcast Scheduled for March 1
14/02/2019 -
Annual General Meeting in ALK-Abelló A/S on 13 March 2019
14/02/2019
Pages